InvestorsHub Logo
Followers 16
Posts 1586
Boards Moderated 0
Alias Born 07/07/2015

Re: dogn post# 405819

Wednesday, 03/15/2023 4:56:09 PM

Wednesday, March 15, 2023 4:56:09 PM

Post# of 428437
I believe Ridker has some patents around hsCRP and I seem to recall his benefiting financially from royalties.

Despite much research on IPE being a powerful anti-inflammatory, he neglects to mention this. hsCRP was reduced 36% in the MARINE trial and 22% in the ANCHOR trial.

In his suggestions for addressing inflammation, he does not mention IPE.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News